Yusen Liu Selected Research

Dual Specificity Phosphatase 1

8/2015	Mitogen-activated protein kinase phosphatase-1 prevents lipopolysaccharide-induced apoptosis in immature rat intestinal epithelial cells.
2/2011	Dysregulation of p38 and MKP-1 in response to NOD1/TLR4 stimulation in sarcoid bronchoalveolar cells.
1/2006	MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yusen Liu Research Topics

Disease

8	Inflammation (Inflammations) 01/2022 - 01/2012
7	Hypoxia (Hypoxemia) 01/2022 - 05/2010
7	Neoplasms (Cancer) 01/2018 - 04/2002
6	Infections 01/2022 - 02/2007
6	Vascular Remodeling 01/2022 - 10/2005
5	Hypotension (Low Blood Pressure) 10/2009 - 01/2006
4	Pulmonary Hypertension 01/2020 - 10/2005
4	Septic Shock (Toxic Shock Syndrome) 01/2012 - 04/2006
3	Lung Injury 01/2022 - 01/2019
3	Escherichia coli Infections 01/2022 - 12/2009
3	Bacterial Infections (Bacterial Infection) 01/2021 - 08/2013
3	Sepsis (Septicemia) 12/2018 - 12/2009
2	Lung Diseases (Lung Disease) 01/2022 - 03/2005
2	Acute Lung Injury 01/2022 - 01/2019
2	Bronchopulmonary Dysplasia 01/2020 - 11/2010
2	Endotoxemia 03/2012 - 11/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2010 - 04/2006
2	Autoimmune Diseases (Autoimmune Disease) 03/2009 - 12/2002
2	Rheumatoid Arthritis 03/2009 - 04/2006
1	Neuroinflammatory Diseases 01/2022
1	Pulmonary Edema 01/2022
1	Uveitis 01/2022
1	Pathologic Processes 12/2021
1	Gestational Diabetes (Gestational Diabetes Mellitus) 11/2021
1	Insulin Resistance 11/2021
1	Acute-Phase Reaction 01/2020
1	Hyperoxia 01/2019
1	Carcinoma (Carcinomatosis) 01/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018
1	Osteosarcoma (Osteogenic Sarcoma) 03/2017
1	Necrotizing Enterocolitis 01/2017
1	Necrosis 12/2012
1	Liver Failure 12/2012
1	Hypothermia 06/2012
1	Sarcoidosis (Schaumann Disease) 02/2011

Drug/Important Bio-Agent (IBA)

14	CytokinesIBA 01/2022 - 01/2006
13	Proteins (Proteins, Gene)FDA Link 12/2021 - 04/2002
7	Mitogen-Activated Protein KinasesIBA 01/2022 - 04/2008
7	Phosphotransferases (Kinase)IBA 05/2010 - 04/2002
6	ArginaseIBA 01/2018 - 02/2006
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2011 - 12/2004
4	LipopolysaccharidesIBA 01/2022 - 01/2006
3	Epidermal Growth Factor (EGF)IBA 01/2022 - 03/2017
3	ErbB Receptors (EGF Receptor)IBA 01/2022 - 03/2017
3	Neutralizing AntibodiesIBA 01/2022 - 03/2017
3	Mitogen-Activated Protein Kinase PhosphatasesIBA 01/2022 - 03/2010
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 01/2017
3	Messenger RNA (mRNA)IBA 01/2018 - 03/2012
3	Small Interfering RNA (siRNA)IBA 03/2017 - 09/2006
3	Dual Specificity Phosphatase 1IBA 08/2015 - 01/2006
3	MitogensIBA 05/2010 - 02/2007
2	Triglycerides (Triacylglycerol)IBA 11/2021 - 12/2018
2	src-Family KinasesIBA 01/2021 - 01/2016
2	Interleukin-10 (Interleukin 10)IBA 01/2021 - 03/2010
2	Glutathione Reductase (Glutathione-Disulfide Reductase)IBA 10/2019 - 08/2013
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2019 - 11/2016
2	JNK Mitogen-Activated Protein KinasesIBA 12/2018 - 12/2012
2	LipidsIBA 12/2018 - 03/2010
2	U 0126 (UO 126)IBA 01/2017 - 07/2006
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2017 - 03/2010
2	Interleukin-1beta (Interleukin 1 beta)IBA 01/2017 - 12/2004
2	Arginine (L-Arginine)FDA Link 11/2016 - 01/2013
2	GlucocorticoidsIBA 06/2012 - 12/2002
2	LigandsIBA 02/2011 - 01/2009
1	B7-H1 AntigenIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Conditioned Culture MediaIBA 01/2022
1	Interferon Type IIBA 01/2022
1	NF-kappa B (NF-kB)IBA 01/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022
1	Galectin 3 (LGALS3)IBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	Blocking AntibodiesIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Dual-Specificity PhosphatasesIBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	ChemokinesIBA 10/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	Peroxidase (Myeloperoxidase)IBA 01/2019
1	Amino Acids FDA Link 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2018
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2018
1	Prokaryotic Initiation Factor-3IBA 01/2018
1	RTKI cpdIBA 01/2017
1	Acetaminophen (Paracetamol)FDA LinkGeneric 12/2012
1	Pharmaceutical PreparationsIBA 12/2012
1	Alanine Transaminase (SGPT)IBA 12/2012
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 06/2012
1	Vitamin D FDA LinkGeneric 03/2012
1	GTP-Binding Proteins (G-Protein)IBA 01/2012
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2012
1	Interleukin-12 (IL 12)IBA 02/2011
1	NucleotidesIBA 02/2011
1	Toll-Like Receptor 4IBA 02/2011
1	ThioredoxinsIBA 11/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2010

Therapy/Procedure

3	Therapeutics 01/2022 - 12/2002
2	Ligation 12/2009 - 04/2002